Avraham Pharmaceuticals Ltd.
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.avphar.com
Clinical Trials
7
Active:5
Completed:2
Trial Phases
2 Phases
Phase 1:2
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Phase 2
2 (50.0%)A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment
Phase 2
Completed
- Conditions
- Mild Cognitive ImpairmentDementia
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-09-07
- Last Posted Date
- 2017-06-15
- Lead Sponsor
- Avraham Pharmaceuticals Ltd
- Target Recruit Count
- 210
- Registration Number
- NCT01429623
- Locations
- 🇦🇹
Medizinische Universitat Graz, Abteilung fur Neurologie, Graz, Austria
🇦🇹Landeskrankenhaus Hall, Memory Klinik, Hall in Tirol, Austria
🇦🇹Privatordination Rainer, Wien, Austria
Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
Phase 2
Completed
- Conditions
- Alzheimer's DiseaseDementiaMemory LossCognitive Impairment
- Interventions
- First Posted Date
- 2011-05-17
- Last Posted Date
- 2020-07-30
- Lead Sponsor
- Avraham Pharmaceuticals Ltd
- Target Recruit Count
- 200
- Registration Number
- NCT01354691
- Locations
- 🇦🇹
Medizinische Univeritat Graz, Universitatsklinik fur Neurologie, Auenbruggerplatz 22, Graz, Austria
🇦🇹Privatordination Horn, HamerlingstraBe 15, Horn, Austria
🇦🇹Allgemeines Krankenhaus der Stadt Linz, KrankenhausstraBe 9, Linz, Austria
News
No news found